Ivacaftor
Anosmia
University of California, Los AngelesSmall moleculeUnknownActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Anosmia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ELEXACAFTOR University of California, Los Angeles | Unknown | D |
Tezacaftor University of California, Los Angeles | Unknown | D |
Cyr-064 University of Nebraska | Phase 1 | NR |
Same molecule, other indications
Ivacaftor is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →